Palliative cancer patients may benefit from ditching unneeded statins

NCT ID NCT07543432

Recruiting now Symptom relief Sponsor: Stiftelsen Stockholms Sjukhem Source: ClinicalTrials.gov ↗

First seen Apr 26, 2026 · Last updated May 15, 2026 · Updated 3 times

Summary

This study looks at whether it is safe and helpful to stop taking statins (cholesterol-lowering drugs) in people with advanced cancer who are receiving palliative care. Statins are often continued even when they may no longer be needed, causing side effects like muscle weakness and fatigue. The study will follow 80 participants for 12 weeks to measure changes in cholesterol, muscle strength, fatigue, and quality of life after stopping statins.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

ASIH Stockholm Södra
RECRUITING

Stockholm, 12559, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••
Stockholms Sjukhem Pallitive Care
RECRUITING

Stockholm, 11219, Sweden

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

CANCER